Journal
CURRENT PSYCHIATRY REPORTS
Volume 15, Issue 3, Pages -Publisher
SPRINGER
DOI: 10.1007/s11920-012-0347-y
Keywords
Antipsychotics; Anticholinergic; Appetite; Cannabis; Diabetes; Diet; Insulin; Leptin; Ketogenic; Metabolic syndrome; Metformin; Prevention; Thirst; Weight gain; Behavioral interventions; Psychotic disorders; Psychiatry
Categories
Funding
- Kiener Press (Kiener-Verlag)
- CPD Online (Royal College of Psychiatrists)
- Janssen
- Bristol-Myers Squibb
- Servier
- Wiley-Blackwell
- ILSI North America
Ask authors/readers for more resources
Weight gain remains a well recognized yet difficult to treat adverse effect of many anti-psychotic drugs including agents of the first and second generation. The weight gain liabilities of antipsychotic drugs are partly associated with their ability to increase appetite. Most behavioral interventions for weight control remain of limited efficacy, possibly because they do not specifically target the neuroendocrine factors regulating appetite. Identifying new weight management interventions directly acting on the biochemical and neuroendocrine mechanisms of anti-psychotic induced weight gain may help to improve the efficacy of behavioral weight management programs. Such potentially specific strategies include (1) using diets which do not increase appetite despite calorie restriction; (2) countering thirst as an anticholinergic side-effect; (3) discouraging cannabis use and (4) adding metformin to a behavioral intervention. In view of our currently rather limited treatment repertoire it seems timely systematically to explore such novel options.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available